Gait and upper-limb movement monitoring for healthy volunteers
Gait Analysis Parameter and Upper Limb Evaluation in Control Participants
This project will test a wrist-and-ankle wearable called Syde® to track walking and arm movements in healthy volunteers of all ages over two years.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de Liege Academic / other |
| Locations | 1 site (Liège) |
| Trial ID | NCT07136506 on ClinicalTrials.gov |
What this trial studies
This monocentric, fully remote study will enroll 200 healthy volunteers across the lifespan and collect continuous wrist-and-ankle movement data using the Syde® device. Participants will wear the device for 3-week periods every six months and complete all consent and follow-up visits remotely by phone or video. The primary aims are to build a normative longitudinal database of gait and upper-limb metrics and to measure device adherence and acceptability. Secondary aims include evaluating the reliability of digital endpoints and how demographic and lifestyle factors influence these measures.
Who should consider this trial
Good fit: Ideal candidates are healthy males or females of any age who can walk at least 10 meters unaided, have a BMI between 17 and 30, can comply with remote procedures, and have reliable internet access or the ability to upload device data onsite.
Not a fit: People with conditions affecting gait or recent limb surgery/trauma, pregnant women, elite national-level athletes, or those without reliable internet access are unlikely to be eligible or to benefit from this normative dataset.
Why it matters
Potential benefit: If successful, this work will produce age- and demographic-specific reference values for wearable-derived movement measures that can improve interpretation of digital endpoints and help design better neurological and rare-disease trials.
How similar studies have performed: Wearable measures from Syde® and ActiMyo® have been used successfully in DMD, SMA, and other populations and the SV95C metric has EMA endorsement, but assembling a full lifespan normative dataset is a novel extension.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male and female of different age groups * Signed informed consent form by participant him/herself or, in case of patients \<18 years old, signed informed consent form by patient's parents or legal guardians * Able to ambulate (minimum 10 meters without help) * Participants with a reported BMI ≥17 and ≤30 * Participant willing and able to comply with all study procedures Exclusion Criteria: * Patients who have undergone a surgical procedure or who have experienced recent trauma (within fewer than 6 months) affecting the upper or lower limbs * Elite athletes (at the national level) * Pregnant women * A chronic or acute muscular, neurological, infectious, or inflammatory pathology within the 3-week period immediately prior to inclusion * An orthopedic, neuromuscular, or neurological pathology that affects the quality of the participant's walking gait * No access to unlimited internet connection or alternatively no capacity to come on-site to upload Syde data
Where this trial is running
Liège
- Centre de référence des maladies neuromusculaire, Centre Hospitalier Régional de la Citadelle — Liège, Belgium (Recruiting)
Study contacts
- Principal investigator: Laurent Servais, MD — Centre Hospitalier Universitaire de Liege
- Study coordinator: Nicolas Bovy
- Email: Nicolas.Bovy@citadelle.be
- Phone: +3243218095
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.